Older patients and women with T2D were shown to have higher levels of oxidative stress and pro-inflammatory cytokines, including IL-23, indicating the need for personalized, sex- and age-sensitive approaches in diabetes management [135]. This evidence concerns the gene IL23A and type 2 diabetes mellitus.